Sherman L - Search Results

1

Interdomain binding mediates tumor growth suppression by the NF2 gene product.

Sherman L, Xu HM, Geist RT, Saporito-Irwin S, Howells N, Ponta H, Herrlich P, Gutmann DH. Sherman L, et al. Oncogene. 1997 Nov 13;15(20):2505-9. doi: 10.1038/sj.onc.1201418. Oncogene. 1997. PMID: 9395247

2

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.

Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H, Herrlich P. Morrison H, et al. Among authors: sherman ls. Genes Dev. 2001 Apr 15;15(8):968-80. doi: 10.1101/gad.189601. Genes Dev. 2001. PMID: 11316791 Free PMC article.

3

Merlin: hanging tumor suppression on the Rac.

Sherman LS, Gutmann DH. Sherman LS, et al. Trends Cell Biol. 2001 Nov;11(11):442-4. doi: 10.1016/s0962-8924(01)02128-6. Trends Cell Biol. 2001. PMID: 11684412

4

CD44: from adhesion molecules to signalling regulators.

Ponta H, Sherman L, Herrlich PA. Ponta H, et al. Among authors: sherman l. Nat Rev Mol Cell Biol. 2003 Jan;4(1):33-45. doi: 10.1038/nrm1004. Nat Rev Mol Cell Biol. 2003. PMID: 12511867 Review.

5

Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression.

Sherman L, Sleeman J, Herrlich P, Ponta H. Sherman L, et al. Curr Opin Cell Biol. 1994 Oct;6(5):726-33. doi: 10.1016/0955-0674(94)90100-7. Curr Opin Cell Biol. 1994. PMID: 7530464 Review.

6

Schwann cell tumors express characteristic patterns of CD44 splice variants.

Sherman L, Skroch-Angel P, Moll J, Schwechheimer K, Ponta H, Herrlich P, Hofmann M. Sherman L, et al. J Neurooncol. 1995 Dec;26(3):171-84. doi: 10.1007/BF01052620. J Neurooncol. 1995. PMID: 8750183 Review.

7

Analysis of molecular functions of the tumor metastasis promoting surface molecule CD44v4-v7 using transgenic mice.

Moll J, Sleeman J, Kondo K, Hekele A, Plug R, Sherman L, Ponta H, Herrlich P, Schmidt A, Zöller M, et al. Moll J, et al. Among authors: sherman l. Princess Takamatsu Symp. 1994;24:142-51. Princess Takamatsu Symp. 1994. PMID: 8983071 Review.

8

CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene.

Sherman L, Jacoby LB, Lampe J, Pelton P, Aguzzi A, Herrlich P, Ponta H. Sherman L, et al. Cancer Res. 1997 Nov 1;57(21):4889-97. Cancer Res. 1997. PMID: 9354454

9

A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth.

Sherman L, Wainwright D, Ponta H, Herrlich P. Sherman L, et al. Genes Dev. 1998 Apr 1;12(7):1058-71. doi: 10.1101/gad.12.7.1058. Genes Dev. 1998. PMID: 9531542 Free PMC article.

10

How tumor cells make use of CD44.

Herrlich P, Sleeman J, Wainwright D, König H, Sherman L, Hilberg F, Ponta H. Herrlich P, et al. Among authors: sherman l. Cell Adhes Commun. 1998;6(2-3):141-7. doi: 10.3109/15419069809004470. Cell Adhes Commun. 1998. PMID: 9823465 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

922 results

Search Page